Theme: A LifeSaving Mission to End Cancer Forever
Cancer Treatment 2019
We welcome all the Oncologists and Cancer Researchers around the world to attend the "2nd International Conference on Cancer Diagnosis and Treatment" going to be held in Paris, France from March 20-21, 2019.
Cancer Diagnosis and Treatment conference 2019 will acts as a forum for Directors, Professors, Researchers, Oncologists, Cancer Specialist, Students, Foundation Leaders, Industrial Professional, Statisticians, Clinicians, Academicians, Medical Oncologists and others from all over the world to share their values knowledge and experience about the Cancer research, to stimulate Young Researcher on new ideas for treatment and analyses of the current market and for the future direction in cancer vaccine, instrument with less side effect of therapy.
Cancer Diagnosis and Treatment Conference 2019 involved with many interactive sessions on cancer detection, therapies, control, prevention, advancements in the oncology, posters, symposia, workshops, panel discussion, industry presentation, exhibition, Young Researcher Forums(YRF).
We hope to see you at Cancer Diagnosis & Treatment 2019……
Cancer Scientists and researchers in the broad areas of Oncology, are most likely to attend and utilize the scope of extending their skills, work on basic and significant applications and doing their masters and research work in programming building streams are most likely to attend this conference.
- Cancer Diagnosis professionals
- Biobank Researchers
- Surgical and Medical oncologist
- Research Scholars
- Nurse practitioners
- Hematology Associations & Societies
- Health professionals
- Software Developing Companies
- Medical Devices Companies
- Business Entrepreneurs
- Drug manufacturing companies
- Data Management Companies
- Biomedical Companies
- Biotechnology Companies
- Experts from Industry and Academic
With people from around the world focused on getting some answers concerning Cancer Diagnosis and Treatment, this is your single most obvious opportunity to achieve the greatest accumulation of individuals from the mending focuses, Universities, bunch, etc. This Cancer Diagnosis & Treatment conference in 2019 will coordinate appears, disperse information, and meet with recurring pattern and potential investigators and get name affirmation at this 2-day event.
- Insights of the Cancer Diagnosis and Treatment 2019 conferences
- Meet the oncologists from 25+ countries.
- Interactive session discussion.
- Share and evaluate your research with global experts
- Best forum to exhibit your products and services.
- Symposia/ workshop, B2B and interaction session.
Track 1: Organ Specific Cancer: Diagnosis & Treatment
Organ Specific Cancer is usually named based on the location of the Cancer cell in the body organ. There are more than 100 types of Cancer and it may occur anywhere in the human body. Breast Cancer is most common in Women, and Prostate cancer is common in Men. Lung cancer and colorectal cancer occurs commonly in both men and women. Cancer also defined by the type of the cell formed them, like epithelial or squamous cell. There are different types of Cancers based on location of cancer in the body organ. These types of Malignancies come under the category of Organ Specific Cancer.
- Breast Cancer
- Lung Cancer
- Prostate Cancer
- Ovary Cancer
- Non Hodgkin Lymphoma
- And Others
Track 2: Cancer Epidemiology, Screening, Diagnosis & Prognosis
The Epidemiology of Cancer is the study of the factors affecting Cancer, a way to conclude possible tendencies and causes. The study of Cancer Epidemiology practices Epidemiological Methods to discover the cause of Cancer and to recognize and develop enhanced treatments. This extent of study must cope with difficulties of lead time bias and length time bias. Lead time bias is the theory that primary diagnosis may artificially inflate the survival statistics of a Cancer, without actually improving the natural history of the disease. Length bias is the concept that tender growing, more lethargic Tumors are more likely to be recognised by Screening Tests, but improvements in diagnosing more cases of indolent Cancer may not translate into better patient outcomes after the implementation of Screening Programs.
Most Cancers are originally known either because of the appearance of signs or symptoms or through Screening. Neither of these leads to a Definitive Diagnosis, which comprises the examination of a tissue sample by a pathologist. People with suspected Cancer are observed with medical tests. These generally include Blood Tests, CT Scans, X-rays and Endoscopy.
Screenings can find initial Cancer, when it’s most curable. Cancer Screening aims to identify Cancer before symptoms appear. This may include blood tests, urine tests, other tests, or Medical Imaging. The aids of screening in terms of Cancer Prevention, early detection and subsequent treatment must be weighed beside any harm. Worldwide screening, Population Screening or Mass Screening involves screening everyone, generally within a definite age group. Selective Screening detects people who are known to be at advanced risk of developing Cancer, such as people with a family history of Cancer.
- Microfluidic device for cancer screening
- Cancer Staging
- Early detection and diagnosis of Cancer
- Circulating tumor cells (CTCs) towards cancer Diagnosis
- Cohort studies and Cancer Survival analysis
Track 3: Radiology & Imaging in Cancer Diagnosis & Therapy
Radiation therapy uses great energy element or radiation or waves such as x-rays, gamma rays, electron beams, protons to abolish or shrink Cancer cell. When compared to normal cell, the Cancer cells grow and split faster, radiation works by making minor breaks in the DNA inside the cells. Cancer cells whose DNA is damaged by radiation stops dividing or die. The normal cell current nearby Cancer cells can also be affected by radiation, leading to side effects. Radiation therapy may be used alone or in combination with surgery Immunotherapy and Chemotherapy. The radiation can be given in 3 ways dependent upon the type of Cancer and position. Types of radiation are external radiation, internal radiation, systemic radiation and others.
Cancer Imaging is the term that covers many methods used in diagnoses and Research Cancer. It is initially used to diagnose and stage the disease and now it is also used to assist with surgery and Radiotherapy, to recognise patients who are responding to treatment and to look for early responses.
- Endoscopy, Colonoscopy and Sigmoidoscopy
- Imaging tests: X-ray, PET, CT, MRI, Mammography, ultrasound etc.
- Nuclear medicine scans, bone scans, Fluoroscopy, SPECT and other methods
Track 4: Cancer Genetics and Epigenetics
Cancer is basically a disease of tissue growth regulation. In order for a normal cell to transform into a Cancer cell, the genes that control cell growth and variation must be altered. The affected genes are divided into two broad categories: Oncogenes and Tumor Suppressor Genes. Oncogenes are genes that stimulate cell growth and reproduction. Tumor Suppressor Genes are genes that prevent cell division and survival. Malignant alteration can arise through the development of novel Oncogenes, the unfortunate over-expression of typical Oncogenes, or by the under-expression or inactivating of Tumor Suppressor Genes. Usually, alterations in Multiple Genes are essential to transform a normal cell into a Cancer cell.
Cancer Epigenetics deals with the Epigenetic Alterations to the genome of Cancer cells that do not comprise any change in the nucleotide sequence. Epigenetic Alterations are as vital as Genetic Mutations in a normal cell conversion to Cancer cells, and their manipulation holds great promise for Cancer prevention, detection, and therapy.
Track 5: Nanotechnology in Cancer Treatment
The Nanoparticles or Nanotechnology in Cancer Treatment deals with destruction, detection, and elimination of the cancer cells with minimal harm to the healthy tissue present near. Nanoparticles are inoculated directly into the cancer cells and can destroy the proliferation of the Cancer cell present inside. Nanoparticle plays major role in drug delivery to overcome the limits of conventional treatment methods.
- Delivering life through chemotherapy
- Nano therapy for Cancer
- Augmenting radiotherapy
Track 6: Cancer Preventive Vaccines: Oncolytic Therapy & Others
Cancer vaccines stimulate the immune system’s capability to protect the body against the infectious agents that may cause disease. Cancer vaccine is also known as biological response modifiers. There are two types of cancer vaccine: Preventive vaccine and treatment vaccine. The Preventive vaccine is used to stop the development of the Cancer cell and treatment vaccines are used to treat the existing cancer by natural immune system to fight against the cancer.
Oncolytic Virus is a virus that infects and breakdown Cancer cells but not normal cells. Oncolytic virus therapy may make it easier to kill tumor cells with chemotherapy and radiation therapy. It is a type of targeted therapy. Also called oncolytic virotherapy, viral therapy, and virotherapy.
- Human papillomavirus (HPV) vaccine
- Hepatitis B virus (HBV)vaccine
Track 7: Precision Medicine and Immuno-Oncology
Precision medicine or personalized medicine is an approach to individual care for selecting treatment that are helpful to the patients based on a genetic understanding of their disease. Depending upon the type of cancer, its size and proliferation, combination of Treatment surgery, Chemotherapy, Radiation therapy and Immunotherapy may vary. But in precision medicine, information about genetic changes in the tumor can be helping to decide the Treatment.
Cancer Immunology is concerned with Immune system in progression and development of Cancer. The most well-known application is Cancer Immunotherapy where the immune system is used to treat cancer.
- Novel concepts in Bi-specific Antibodies Engineering
- Pre-clinical and Translational Immuno-Oncology Developments
- Personalized Immunotherapy, Combination Immunotherapy and Viral Therapies
Track 8: Circulating Tumor Cell (CTC)
Circulating Tumor Cell are the cells that are shed into the lymphatic or vasculature stream from a tumor and remain loose in circulation, cluster together as they travel or lodge themselves in new tissues. The detection of Circulating tumor cell has important Diagnostic and Therapeutic implication then their number can be very small and cells are not certainly identified.
- Methods of CTC detection
- CTC number as a surrogate response and prognostic biomarker
- CTC chip technology and EGFR mutation analysis
- Application of CTC technologies to clinical testing
Track 9: Cell and Gene Therapy for Cancer
Cell Therapy goes for focusing on different diseases at the cellular level, i.e. by re-establishing a definite cell populace or using cells as therapeutic cargo. Gene Therapy deals with biomedical investigation with the objective of impacting the course of different hereditary and procured diseases at the DNA/RNA level. For utmost diseases, cell and gene therapy are applied in combination. Moreover, these two fields have given ideas, reagents, and techniques that are lighting up the improved purposes of quality control, stem cell lineage, cell-cell interactions, input circles, enhancement circles, regenerative limit, and redesigning or remodeling.
- Understanding of the genetic basis of cancer
- Developed methods for isolating, expanding and engineering cancer-killing cells
- Enhancing the immunogenicity of the tumor by introducing genes therapy
Track 10: Targeted Cancer Therapy
Targeted Cancer Therapy is one of the chief means of medical treatment for Cancer. Targeted Therapy blocks the development of Cancer cells by interfering with Specific Targeted Molecules required for carcinogenesis and tumor growth rather than by simply interfering with all rapidly dividing cells. Targeted Cancer Therapies are likely to be more effective than older forms of treatments and less harmful to normal cells. Numerous Targeted Therapies are examples of immunotherapy using immune mechanisms for therapeutic purposes developed by the field of cancer immunology. So, as immunomodulators, they are one type of biological response modifiers.
- FDA approved Targeted Therapies for Cancer
- Monoclonal Antibody-conjugated Nanoparticles for Targeted Cancer Therapy
- Types of targeted therapies: hormone therapies, signal transduction inhibitors, expression modulators, apoptosis inducers, angiogenesis inhibitors, toxin delivery molecules etc.
- Molecular targeted therapies
Track 11: Cancer Clinical Trials
Clinical trials for cancer are research studies that relate the most effective well-known treatment for a specific type or stage of cancer with a novel approach. This can be a new drug, or combination of drugs or a unlike way of using established therapies. There are trials that comprise new approaches to surgery and radiation treatment. There are clinical trials for each type of cancer. Though many trials focus on late stage disease, there are also trials to prevent cancer, improve early diagnosis, stop the cancer from coming back, reduce side effects or improve quality of life.
Track 12: Cancer Control and Palliative Care
Cancer control is intended to decrease the Cancer cases, death and cause in the behavioral, social, population sciences to generate intervention, research in the biomedical instrumentation, morbidity, and mortality to progress the quality of life.
Palliative care is a special method for specialized medical and nursing care for individual with life-limiting or bed ridden sickness. Palliative care is also termed as comfort care, supportive care and system management to inhibit or treat diseases. Different types of Palliative care are given to the patient liable upon the emotional issues of Cancer and by addressing the side effects.
- Hospice in cancer
Track 13: Cancer Biology and Drug Delivery
A term for diseases in which abnormal cells divide without control and can attack nearby tissues. Cancer cells can also spread to new parts of the body through the blood and lymph systems. There are numerous main types of cancer. Carcinoma is a cancer that originates in the skin or in tissues that line or cover interior organs. Sarcoma is a cancer that originates in bone, cartilage, fat, muscle, blood vessels, or other connective or supportive tissue. Leukemia is a cancer that starts in blood-forming tissue, such as the bone marrow, and causes large amounts of abnormal blood cells to be produced and enter the blood. Lymphoma and multiple myeloma are cancers that arise in the cells of the immune system. Central nervous system cancers are cancers that arise in the tissues of the brain and spinal cord they are also called malignancy.
Medication conveyance refers to plans, approaches, advances, and frameworks for carrying a pharmaceutical compound in the body as estimated to securely achieve its desired curative effect. It might contain logical site-focusing inside the body, or it may include encouraging fundamental pharmacokinetics; regardless, it is commonly worried about both amount and length of medication nearness. Medication conveyance is commonly drawn closer by means of a medication's synthetic definition; however it might likewise include medicinal devices or medication device mix items. Medication conveyance is an idea strongly coordinated with measurement shape and course of organization, the last here and there being considered piece of the definition. Drug delivery technologies alter drug release profile, absorption, distribution and elimination for the benefit of improving product efficacy and safety, as well as patient convenience and compliance.
Track 14: Cancer Pharma Industry
Cancer is one of the best wellbeing challenges, and a chief cause of death in each edge of the world. The international market for Cancer drugs is anticipated to develop twice as quick as that of different pharmaceuticals throughout the following couple of years. Top organizations incorporate Janssen biotech, Boehringer ingelheim, Roche, Celgene, Takeda oncology, Novartis, Johnson and Johnson, and Amgen. The growth business is the most usually profitable business in the USA. It has been seen that, there are 1,665,540 novel malignancy cases analyzed and 585,720 growths short-lived in the US in the year 2014. $6 billion of citizen stores are turned through different government organizations for malignancy explore for the most part as the National Cancer Institute . The NCI states that the restorative expenses of disease mind are $125 billion, with the ascent of 39 percent to $173 billion by the up and coming year that is 2020. The most renowned maxim of the growth business is it exploits an excessive number of individuals and delivers excessively pay to enable a cure to be found.
Track 15: Alternative Treatment and Cancer Therapy
Cancer can be treated by many methods, such as surgery, chemotherapy, radiation therapy, targeted therapy, hormonal therapy, and synthetic lethality. People suffering from cancer can be examined through medical tests. These generally include blood tests are X-rays, CT scans, and endoscopy. The tissue investigation from the biopsy specifies the type of cell that multiplies, through its histological grade, genetic abnormalities, and other features. Thus all together it gives the user information about molecular changes such as mutations, fusion genes, and numerical chromosome to estimate or show the prognosis and to choose the best treatment. Cytogenetics and immunohistochemistry are other common tissue tests. The elimination of cancer without damaging the other parts of the body (by achieving cure with near-zero adverse effects) is the key goal of treatment. The type of treatment depends on the type of cancer the patient is suffering with and how advanced it is. Various people with cancer have only one type of treatment. But for maximum of the people, they have a combination of treatments, such as surgery with chemotherapy (use of drugs to kill cancer cells) or radiation therapy. Immunotherapy, targeted therapy, or hormone therapy are alternative kind of treatment for cancer.
Track 16: Novel Approaches to Cancer Treatment
The usual treatment modalities are associated with severe side effects and high toxicity which in turn lead to low quality of life. This analysis encompasses novel strategies for more effective chemotherapeutic delivery aiming to generate better prognosis. Presently, cancer management is a highly dynamic field and significant advances are being made in the growth of novel cancer treatment strategies. In contrast to conventional cancer therapeutics, novel methods such as ligand or receptor based targeting, intracellular drug targeting, gene delivery, cancer stem cell therapy, magnetic drug targeting and ultrasound-mediated drug delivery, have added novel modalities for cancer treatment.
Track 17: Anti-Cancer Drug Discovery and Development
Drug discovery and development together are the complete practice of identifying a new drug and passing it to market. Discovery might include screening of chemical libraries, identification of the active ingredient from a natural remedy or design resulting from an understanding of the target.
Track 18: Cancer immunotherapy: Car T Cell Technology
A type of treatment in which a patient’s T cells (a type of immune cell) are altered in the laboratory so they will bind to cancer cells and destroy them. Blood from a vein in the patient’s arm flows through a tube to an apheresis machine (not shown), which eliminates the white blood cells, including the T cells, and directs the rest of the blood back to the patient. Then, the gene for a special receptor named a chimeric antigen receptor (CAR) is introduced into the T cells in the laboratory. Millions of the CAR T cells are developed in the laboratory and then given to the patient by infusion. The CAR T cells are able to bind to an antigen on the cancer cells and destroy them.
- CAR-T cell therapy in acute lymphoblastic leukaemia
- CAR-T cells therapy in chronic lymphocytic leukaemia
- CAR-T cell in multiple myeloma
- Organ Specific Cancer: Diagnosis & Treatment
- Cancer Epidemiology, screening, Diagnosis & Prognosis
- Radiology & Imaging in Cancer Diagnosis & Therapy
- Cancer Genetics and Epigenetics
- Nanotechnology in Cancer Treatment
- Cancer Preventive Vaccines: Oncolytic Therapy & Others
- Precision Medicine and Immuno-Oncology
- Circulating Tumor Cell (CTC)
- Cell and Gene Therapy for Cancer
- Targeted Cancer Therapy
- Cancer Clinical Trials
- Cancer Control and Palliative Care
- Cancer Biology and Drug Delivery
- Cancer Pharma Industry
- Alternative Treatment and Cancer Therapy
- Anti-Cancer Drug Discovery and Development
- Novel Approaches to Cancer Treatment
- Cancer immunotherapy: Car T Cell Technology
To share your views and research, please click here to register for the Conference.